IMPROVING ONCOLOGY EXPLORATION WITH INTEGRATED KRAS ASSAY COMPANIES AND RAS ASSAYS

In the fast evolving industry of oncology analysis, accurate and efficient mutation screening is vital for creating qualified therapies. The KRAS solutions Platform performs a pivotal position In this particular landscape by offering in depth remedies for KRAS mutation profiling and analysis. KRAS mutations, present in approximately ninety five% of